Pharmaceutical Liability News: Baxter notifies FDA of HYLENEX recombinant recall
News for pharmaceutical liability attorneys—Baxter International Inc. participated with FDA to issue defective product recall of HYLENEX recombinant.
News for pharmaceutical liability attorneys—Baxter International Inc. participated with FDA to issue defective product recall of HYLENEX recombinant.
Product liability attorneys: Hylenex has restructuring errors, according to Halozyme Therapeutics.
Baxter International, Inc., a medical product maker settled drug injury lawsuit with Illinois Attorney General for $6.8 million. Deerfield based medical device and drug manufacturing
News for pharmaceutical liability attorneys—Baxter International Inc. participated with FDA to issue defective product recall of HYLENEX recombinant.
Product liability attorneys: Hylenex has restructuring errors, according to Halozyme Therapeutics.
Baxter International, Inc., a medical product maker settled drug injury lawsuit with Illinois Attorney General for $6.8 million. Deerfield based medical device and drug manufacturing